Two years after its introduction, ground-breaking cancer treatment is showing positive results
December 3, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com Two years ago, the cancer experts at OHC were the first independent adult cancer group in the region to (Read More)
Cancer and COVID-19: Celebrate Safe Holidays This Season
November 23, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com As COVID screenings increase and positive results trend up, families are faced with difficult decisions (Read More)
Treatment advancements and awareness are giving patients with pancreatic cancer hope
November 19, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com November is Pancreatic Cancer Awareness Month and the cancer experts at OHC believe the more you know about (Read More)
New FDA-approved treatment for lung cancer is available at OHC
November 10, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com OHC is excited to share that the US Food and Drug Administration has approved a new treatment for (Read More)
OHC is evaluating a promising new treatment for metastatic HER2-positive breast cancer
October 29, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com One of every five breast cancers are HER2-positive breast cancers. This type tends to grow and spread (Read More)
Three Things to Know Before You Cancel Your Mammogram
October 23, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com More than six months into the COVID-19 pandemic, fears are growing about the long-term impact on cancer (Read More)
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com For many women diagnosed with ovarian cancer, their initial treatment, which typically includes (Read More)
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com In the past 40 years, the number of cases of cervical cancer and the number of deaths from cervical cancer (Read More)
OHC is Helping Change the Lives of Patients with Breast Cancer through Clinical Trials
October 12, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com Breast cancer is no longer the most common cancer for women in the United States. This is due to decades (Read More)
OHC doctors are evaluating two new treatments for classic Hodgkin’s lymphoma that may offer fewer, milder side effects.
October 9, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com Classical Hodgkin lymphoma (CHL) is considered a highly treatable blood cancer. Advancements in (Read More)
OHC is honored to have four recipients of the Unsung Hero Awards
October 2, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com In 2003, Cancer Family Care established the Unsung Hero Awards in memory of Joslin Haggart Yeiser. According to (Read More)
OHC Earns Coveted Accreditation for High Quality and Patient Safety from the American College of Radiology
September 25, 2020
The cancer experts at OHC have been awarded a three-year term of accreditation in radiation oncology from the American College of Radiology (ACR), following an extensive and detailed review of the practice’s procedures, staff, equipment, (Read More)
Cancer Experts at OHC are Evaluating a New Treatment for Older Adults with Acute Myeloid Leukemia
September 22, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com Although acute myeloid leukemia (AML) accounts for only about one percent of all cancers, it can be deadly if not (Read More)
OHC is Offering a New Treatment for Men with Advanced Prostate Cancer
September 14, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com Prostate cancer is the second most common cancer among men. The good news is that approximately 90 percent of (Read More)
OHC Is Evaluating a Promising New Treatment for Kidney Cancer
September 10, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com The American Cancer Society estimates that approximately 25 percent of people diagnosed with kidney (renal) (Read More)
